Skip to main content
OpenTrials

Clinical trial condition

Diabetes Mellitus, Type 2

Explore clinical trials studying Diabetes Mellitus, Type 2. Study availability and eligibility vary by location and protocol.

7,977 public trials 716 recruiting studies

Diabetes Mellitus, Type 2 trial results

Conditions
Apnea, Diabetes Mellitus, Diabetes Mellitus Type 2, +15 more
Locations
  • Mission Internal Medical Group Mission Viejo, California, United States
  • Advanced Metabolic Care and Research Institute Temecula, California, United States
  • Clinical Research of South Florida Coral Gables, Florida, United States
  • SleepMed of Central Georgia Macon, Georgia, United States
View all 15 locations
Conditions
Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +3 more
Locations
  • 1218.36.01043 Boehringer Ingelheim Investigational Site Escondido, California, United States
  • 1218.36.01051 Boehringer Ingelheim Investigational Site Escondido, California, United States
  • 1218.36.01065 Boehringer Ingelheim Investigational Site Fresno, California, United States
  • 1218.36.01021 Boehringer Ingelheim Investigational Site Greenbrae, California, United States
View all 169 locations
Conditions
Body Weight, Diabetes Mellitus, Diabetes Mellitus, Type 2, +11 more
Locations
  • Diabetes Research Division, Department of Internal Medicine, Gentofte Hospital, University of Copenhagen Hellerup, Copenhagen, Denmark
Conditions
Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +4 more
Locations
  • Institute of Public Health Aarhus, Denmark
  • Julius Centre for health Sciences and Primary Care, University of Utrecht Utrecht, Netherlands
  • Department of Public Health and general Practice Cambridge, United Kingdom
  • University Hospital and Department of Health Sciences, University of Leicster Leicester, United Kingdom
Conditions
Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +5 more
Locations
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Beijing, China
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Guangzhou, China
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Kunming, China
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Nanjing, China
View all 14 locations
Conditions
Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +6 more
Locations
  • Research Site Nagoya, Aichi-ken, Japan
  • Research Site Owariasahi, Aichi-ken, Japan
  • Research Site Toyohashi, Aichi-ken, Japan
  • Research Site Hirosaki, Aomori, Japan
View all 38 locations